Tuesday , December 12 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 22)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

13 years ago we ran an article on diabetes and dental health. Over the years we have added over 100 items on the relationship of diabetes and mouth health, including many by our feature writer, Dr. Frank Varon, DDS. 10 years ago this week he prepared his first feature on diabetes and periodontal …

Read More »

I just spent the day in a conference talking about the genetic differences in different ethnic groups, and how that affects both causes and treatments for diseases such as cancer, congestive heart failure, and hypertension. I personally know how genetics can have an effect, because I lack the proper gene …

Read More »

February 20, 2106

When the SGLT-2 drugs first came out, there was a big emphasis put on the UTI side-effect, and many prescribers were hesitant to try the class. This proved to be over-exaggerated and prescribers started using them. Further research showed that they could cause weight loss and lower blood pressure, and …

Read More »

According to IMS prescribing data, all of the SGLT-2 inhibitor class drugs are experiencing growth. What is more important is that the 6-month adherence rate is higher than any other branded class. Part of this can be attributed to the 2-year free medication vouchers that all manufacturers offer. However, if …

Read More »

This past week, we had our 3rd endocrinologist retire since December. We have a metropolitan population of just under 3 million people, and now we are down to 17 endocrinologists — and 6 of them only take care of children. Eleven endos for 3 million people is just hard to believe. If …

Read More »

Our diabetes disaster looks at the idea that patients often don’t use the information they have to regulate their blood sugars, and a lot of times this is because the right information only makes things worse. Usually this has to do with insulin dosing, and for many patients it can have …

Read More »

February 6, 2016

The 2016 professional cycling season has started, and this week Team NovoNordisk is competing in the Tour of Dubai. This race brings together professional cycling teams from all over the world and many of the top riders, including 4 former Tour de France winners. As you know, all the TNN …

Read More »

It appears that we are now looking more and more at diabetes as a cardiovascular risk factor, and our therapies and goals for diabetes care need to be targeted in that direction. In order to help make this message as clear as possible, we have focused our homerun slides and …

Read More »

January 30, 2016

I did a quick search, and in the past 2 years we have had over 80 items on food choices and the best way to eat for diabetes. This does not even begin to include the ones we turned down. Often these ideas conflict, and experts flip-flop on what works best …

Read More »

It is very frustrating when we take our time to educate patients on the complications of diabetes and then they flat out ignore us. These patients usually don’t have symptoms that make them feel bad, and so they feel we are overreacting and don’t really listen or make changes. Usually …

Read More »